[Percutaneous treatment of intermediate- and high-risk pulmonary embolism: two case reports]. / Trattamento percutaneo dell'embolia polmonare a rischio intermedio e ad alto rischio: due casi clinici.
G Ital Cardiol (Rome)
; 23(7 Suppl 2): 22S-24S, 2022 07.
Article
em It
| MEDLINE
| ID: mdl-35848914
ABSTRACT
Pulmonary embolism is the third most common cause of cardiovascular emergency. Risk stratification is crucial in the clinical and therapeutic management of these patients. The latest European guidelines introduced a new classification based on short-term mortality risk stratification, dividing patients into four categories (high, intermediate-high, intermediate-low and low risk). Despite the limited evidence in this field, the percutaneous treatment of pulmonary embolism represents an option of interest; however, correct patient selection and device choice should be better investigated. In this article, we present two case reports of patients with intermediate-high-risk and high-risk pulmonary embolism treated with the EkoSonic Endovascular System (EKOS Corp., Bothell, WA, USA) and the FlowTriever System (Inari Medical, Irvine, CA, USA), respectively.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Embolia Pulmonar
/
Terapia Trombolítica
Idioma:
It
Ano de publicação:
2022
Tipo de documento:
Article